Abstract
In recent years, numerous changes have been made in the field of cancer research with the progresses of molecular biology, chemoinformatics and chemogenomics. Several new biomolecular targets have been identified, and investigated for new drug discovery. In the current article, we discuss the role of pharmacophore mapping and pharmacophorebased virtual screening (PBVS) approaches for identification of novel anticancer hits. It showed that pharmacophorebased studies were performed for almost every type of anticancer agents. However, such applications are clustered on finding novel hits for a few targets like cancer-related hormones, kinase enzymes and other less investigated targets. Some reports were found with virtual hits experimentally validated against respective targets. These were thoroughly described and the novel hits were pointed out. Others with PBVS of anticancer targets were also discussed and the identified features were highlighted. Present review showed that PBVS may serve as a true lead generator if it is performed in a unified fashion that combines in silico techniques with experimental validation. With enormous progresses in computational methods as well as molecular biology, it is expected that pharmacophore-based drug discovery strategy will aid in significant upsurge in the field of cancer chemotherapy in near future.
Keywords: Cancer, Cheminformatics, Pharmacophore mapping, Virtual screening, Kinase, Lead identification.
Current Topics in Medicinal Chemistry
Title:The Role of 3D Pharmacophore Mapping Based Virtual Screening for Identification of Novel Anticancer Agents: An Overview
Volume: 13 Issue: 9
Author(s): Amit K. Halder, Achintya Saha and Tarun Jha
Affiliation:
Keywords: Cancer, Cheminformatics, Pharmacophore mapping, Virtual screening, Kinase, Lead identification.
Abstract: In recent years, numerous changes have been made in the field of cancer research with the progresses of molecular biology, chemoinformatics and chemogenomics. Several new biomolecular targets have been identified, and investigated for new drug discovery. In the current article, we discuss the role of pharmacophore mapping and pharmacophorebased virtual screening (PBVS) approaches for identification of novel anticancer hits. It showed that pharmacophorebased studies were performed for almost every type of anticancer agents. However, such applications are clustered on finding novel hits for a few targets like cancer-related hormones, kinase enzymes and other less investigated targets. Some reports were found with virtual hits experimentally validated against respective targets. These were thoroughly described and the novel hits were pointed out. Others with PBVS of anticancer targets were also discussed and the identified features were highlighted. Present review showed that PBVS may serve as a true lead generator if it is performed in a unified fashion that combines in silico techniques with experimental validation. With enormous progresses in computational methods as well as molecular biology, it is expected that pharmacophore-based drug discovery strategy will aid in significant upsurge in the field of cancer chemotherapy in near future.
Export Options
About this article
Cite this article as:
Halder Amit K., Saha Achintya and Jha Tarun, The Role of 3D Pharmacophore Mapping Based Virtual Screening for Identification of Novel Anticancer Agents: An Overview, Current Topics in Medicinal Chemistry 2013; 13 (9) . https://dx.doi.org/10.2174/1568026611313090009
DOI https://dx.doi.org/10.2174/1568026611313090009 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antibody-Onconase Conjugates: Cytotoxicity and Intracellular Routing
Current Pharmaceutical Biotechnology A Concise Review of Current Radiopharmaceuticals in Tumor Angiogenesis Imaging
Current Pharmaceutical Design Nanomedical Applications of Amphiphilic Dendrimeric Micelles
Current Medicinal Chemistry Human Microdialysis
Current Pharmaceutical Biotechnology PEGylated Lipid Nanocapsules with Improved Drug Encapsulation and Controlled Release Properties
Current Topics in Medicinal Chemistry Integrins in Bone Metastasis Formation and Potential Therapeutic Implications
Current Cancer Drug Targets Expression, Distribution and Regulation of Phosphodiesterase 5
Current Pharmaceutical Design ZD6474, a Small Molecule Tyrosine Kinase Inhibitor, Potentiates the Anti-Tumor and Anti-Metastasis Effects of Radiation for Human Nasopharyngeal Carcinoma
Current Cancer Drug Targets Reflecting Back to Bring Nitric Oxide Research to the Laboratory
Current Medicinal Chemistry SALL4: Engine of Cell Stemness
Current Gene Therapy Role of Nuclear Steroid Receptors in Apoptosis
Current Medicinal Chemistry Design of Magnetic Nanoparticles-Assisted Drug Delivery System
Current Pharmaceutical Design Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment
Current Drug Delivery Amyloid-Beta Peptide 1-42 Causes Microtubule Deregulation through N-methyl-D-aspartate Receptors in Mature Hippocampal Cultures
Current Alzheimer Research Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Oncological Submissions of Dendrimer
Current Pharmaceutical Design Stable Expression of the Sodium/Iodide Symporter (NIS) for anti-Cancer Gene Therapy of Glioma Cells Using a Third Generation Self-Inactivating Lentiviral Vector System in Combination with 211At
Current Radiopharmaceuticals Characterization of Cancer Stem Cells and Primary Cilia in Medulloblastoma
CNS & Neurological Disorders - Drug Targets Carbohydrates: Potential Sweet Tools Against Cancer
Current Medicinal Chemistry Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction
Current Pharmaceutical Design